DGKζ-IN-9

• Description:

  DGKζ-IN-9 (compound 73) is a DGKζ inhibitor, with an IC50 ≤200 nM[1].

• UNSPSC:

  12352005

• Target:

  DGK

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Smiles:

  FC1=CC=C(N(C2=NC(N)=C(C(C3=CC=C(OCC4CC4)C=C3)=O)S2)[C@H](C)C(N)=O)C=C1

• Molecular Formula:

  C23H23FN4O3S

• Molecular Weight:

  454.52

• References & Citations:

  [1]BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD. COMPOUND AS DGKΖ INHIBITOR. Patent WO2024235203.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [3062706-10-6]